Business
Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance
Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance.
About this update from Sonendo, Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Sonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance\r\n \r\n \r\n\r\n\r\nSonendo, Inc. Reports Second Quarter 2025 Financial Results and Reaffirms Financial Guidance\r\n\r\n\r\n\r\n\r\n\r\n LAGUNA HILLS, Calif.--(BUSINESS WIRE)--\r\nSonendo, Inc. (“Sonendo” or the “Company”), a leading dental technology company and developer of the GentleWave® System, today reported select financial results for the three-months ended June 30, 2025 and reaffirmed 2025 financial guidance.\r\n\r\n\r\n \r\nSelect Second Quarter Financial Results\r\n\r\n\r\n \r\n \r\nGenerated $7.4 million of total revenue for the second quarter of 2025, an 11% decline compared to the prior year period, which was expected and driven entirely by lower console sales through a smaller and more cost effective sales team;\r\n\r\n\r\n \r\nReported an increase in gross margin to 41% for the second quarter of 2025, up 320 basis points compared to the prior year period;\r\n\r\n\r\n \r\nReported a $3.6 million reduction in loss from continuing operations compared to the prior period, to $3.9 million for the second quarter of 2025;\r\n\r\n\r\n \r\nDrove a 47% year-over-year improvement in Adjusted EBITDA loss to $3.0 million for the second quarter of 2025, driven by focused operational efficiencies;\r\n\r\n\r\n \r\nSignificantly reduced free cash flow burn to $2.6 million, a 61% reduction compared to the prior year period.\r\n\r\n\r\n \r\n \r\n“We are pleased by the continued progress we have made in generating increasing operating leverage in the business, as demonstrated in our second quarter 2025 financial and operational results,” said Bjarne Bergheim, President and Chief Executive Officer of Sonendo. “In particular, we are selling consoles much more efficiently and with a focus on driving higher procedure instrument utilization. We are also focusing the commercial team’s efforts on being more responsive to the clinical needs of our customers and their patients. We recently improved the liquidity profile of the Company in a meaningful way, and we remain steadfastly committed to operational excellence and to position Sonendo for robust, long-term and profitable growth.”\r\n\r\n\r\n \r\nAs of June 30, 2025, the Company’s cash, cash equivalents...